Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Daiichi initiates arbitration proceedings against Singhs of Ranbaxy but is it more symbolic?

This article was originally published in Scrip

Executive Summary

Following through on its May 22 statement, Daiichi Sankyo is said to have moved towards initiating arbitration proceedings in Singapore against the former shareholders of Ranbaxy Laboratories, the Singh brothers, over alleged misrepresentation of critical information concerning the US Department of Justice (DoJ) and FDA investigations against Ranbaxy at the time of the 2008 takeover by the Japanese company.

Advertisement

Related Content

Golden Week For Daiichi: Damages Due From Ranbaxy Brothers

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC023411

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel